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Alkyl-dihydroxyacetonephosphate Synthase
PRESENCE AND ROLE OF FLAVIN ADENINE DINUCLEOTIDE*
(Received for publication, April 12, 1999, and in revised form, November 8, 1999)
Edwin C. J. M. de Vet‡§, Yvonne H. A. Hilkes‡, Marco W. Fraaije¶i, and Henk van den Bosch‡**
From the ‡Centre for Biomembranes and Lipid Enzymology, Institute for Biomembranes, Utrecht University, 3584 CH
Utrecht, The Netherlands and the ¶Department of Genetics and Microbiology, University of Pavia, 27100 Pavia, Italy
Alkyl-dihydroxyacetonephosphate synthase is a per-
oxisomal enzyme involved in ether lipid synthesis. It
catalyzes the exchange of the acyl chain in acyl-dihy-
droxyacetonephosphate for a long chain fatty alcohol,
yielding the first ether linked intermediate, i.e. alkyl-
dihydroxyacetonephosphate, in the pathway of ether
lipid biosynthesis. Although this reaction is not a net
redox reaction, the amino acid sequence of the enzyme
suggested the presence of a flavin adenine dinucleotide
(FAD)-binding domain. In this study we show that alkyl-
dihydroxyacetonephosphate synthase contains an es-
sential FAD molecule as cofactor, which is evidenced by
fluorescence properties, UV-visible absorption spectra
and the observation that the enzyme activity is depend-
ent on the presence of this cofactor in a coupled in vitro
transcription/translation assay. Furthermore, we could
demonstrate that the FAD cofactor directly participates
in catalysis. Upon incubation of the enzyme with the
substrate palmitoyl-dihydroxyacetonephosphate, the
flavin moiety is reduced, indicating that in this initial
step the substrate is oxidized. Stopped flow experiments
show that the reduction of the flavin moiety is a
monophasic process yielding a oxygen stable, reduced
enzyme species. Upon addition of hexadecanol to the
reduced enzyme species, the flavin moiety is efficiently
reoxidized. A hypothetical reaction mechanism is pro-
posed that is consistent with the data in this paper and
with previous studies.
Alkyl-dihydroxyacetonephosphate (DHAP)1 synthase (alkyl-
glyceronephosphate synthase; EC 2.5.1.26) is a key enzyme in
the biosynthesis of glycero-ether lipids. It catalyzes the ex-
change of the acyl chain in acyl-DHAP by a long chain fatty
alcohol, yielding alkyl-DHAP (Scheme 1). Because in this step
the ether linkage is introduced, this enzyme can be considered
to catalyze the most characteristic step in ether lipid synthesis.
In mammals it is clearly established that the enzyme is located
in peroxisomes (1, 2). This is also emphasized by the observa-
tion that the enzyme activity as well as the enzyme protein is
deficient in human genetic diseases in which peroxisome bio-
genesis is disturbed (3, 4). The identification of patients with
deficiencies in ether lipid biosynthetic enzymes, including al-
kyl-DHAP synthase, with severe clinical abnormalities shows
unambiguously that ether lipids are of central importance in
humans (5).
The reaction mechanism of alkyl-DHAP synthase has been
studied extensively in the past using partially purified enzyme
preparations and crude microsomal fractions. Important fea-
tures are: both oxygens of the fatty acid are removed during the
acyl cleavage (6) and the oxygen for the ether linkage to be
formed is donated by the alcohol (7), pointing toward a unique
cleavage mechanism. The pro-R hydrogen at the C-1 position of
the DHAP moiety is exchanged with water during the reaction,
and 1 mol of hydrogen is incorporated from water in alkyl-
DHAP for each mole of product formed (8–10). No Schiff base
was formed during the reaction (11, 12). The kinetic features of
the bisubstrate reaction favors a ping-pong mechanism rather
than a sequential mechanism (13, 14).
The cDNAs encoding alkyl-DHAP synthase have been cloned
from guinea pig (15), man (16), Caenorhabditis elegans (17),
and Dictyostelium discoideum (18). Both mammalian enzymes
carry a peroxisomal targeting signal type 2 in N-terminal
cleavable presequences, whereas the C. elegans and D. discoi-
deum homologs contain C-terminal PTS1 sequences. The ex-
pression of guinea pig alkyl-DHAP synthase in Escherichia coli
(15), as well as the raising of specific antibodies against the
protein, has enabled further characterization of the enzyme.
Although not an integral membrane protein, the enzyme ap-
pears to be tightly bound to the inner aspect of the peroxisomal
membrane (19, 20). Alkyl-DHAP synthase is present in a het-
erotrimeric complex with DHAP acyltransferase, the enzyme
that provides the substrate for alkyl-DHAP synthase (21, 22).
Recently, based on the crystal structure of the fungal fla-
voprotein vanillyl-alcohol oxidase (23) and sequence homology
analysis, a novel oxidoreductase family sharing a conserved
FAD-binding domain was identified (24). Members of this fam-
ily are typically 500–600 amino acids long and consist of two
domains: (i) a conserved FAD-binding domain anchoring the
ADP part of the cofactor which is formed by the N- and C
termini and (ii) a nonconserved variable domain of about 240
residues. Remarkably, also alkyl-DHAP synthase, not cata-
lyzing a net redox reaction, was considered to be a member of
this family on the basis of its primary sequence. Already after
the cloning of the cDNA for human alkyl-DHAP synthase we
have noted a clear homology between alkyl-DHAP synthase
and the FAD containing D-lactate dehydrogenase (cytochrome
c) precursor from Saccharomyces cerevisiae as well as with an
uncharacterized open reading frame product of glycolate oxi-
dase subunit D from E. coli, which are also members of this
novel oxidoreductase family (see Refs. 16 and 24 for alignments
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and references). Mature alkyl-DHAP synthase as well as yeast
D-lactate dehydrogenase carry N-terminal extensions of about
100 amino acids that are not shared by other members of the
family. Because these two enzymes are the only known mem-
brane-associated proteins of this family so far, these extensions
may form membrane anchors. Although existing, examples of
FAD-binding enzymes that do not catalyze net redox reactions
are rare (25, 26). In this paper we show that alkyl-DHAP
synthase does indeed contain FAD and that the flavin part is
actively involved in the formation of the product alkyl-DHAP. A
reaction mechanism is presented that is consistent with the




FAD is a product from Roche Molecular Biochemicals. FMN was
purchased from Sigma. TnT-coupled reticulocyte lysate system was
obtained from Promega (Madison, WI). Amylose resin and the pMAL-c2
vector were obtained from New England Biolabs. ProbondTM metal-
binding resin was from Invitrogen (San Diego, CA). Isopropyl-b-D-thio-
galactopyranoside was a product from Research Organics Inc. (Cleve-
land, OH).
Methods
Purification of Recombinant Poly-histidine-tagged Guinea Pig Alkyl-
DHAP Synthase—Poly-histidine tagged guinea pig alkyl-DHAP syn-
thase was expressed in E. coli strain BL21(DE3) as described (15). After
the induction period, cells (0.7 liters of culture) were harvested by
centrifugation (10 min, 3000 3 g) and resuspended in 30 ml of ice-cold
lysis buffer (20 mM Tris/HCl, 5 mM imidazol, 200 mM NaCl, 0.2% Triton
X-100, and 0.2 mg/ml lysozyme, pH 7.5). After 0.5 h of incubation on ice,
the suspension was sonicated in two parts for five times for 30 s at 90
Watt output with a macro tip of a Sonifier B12 (Branson Sonic Power
Company). All subsequent manipulations were done in a cold room
(4 °C). The suspension was centrifuged for 15 min at 12,000 3 g, and the
supernatant was loaded onto a ProbondTM metal-binding resin column
charged with NiCl2 (1.3 3 6 cm). The flow rate was 30 ml/h. After
application of the sample, the column was washed with 50 ml of wash-
ing buffer (20 mM Tris/HCl, 100 mM imidazol, 200 mM NaCl, 0.2% Triton
X-100, pH 7.5). Recombinant alkyl-DHAP synthase was eluted with a
buffer containing 20 mM Tris/HCl, 400 mM imidazol, and 0.2% Triton
X-100 (pH 7.5). Because of the relatively low protein concentrations and
high Triton X-100 concentration in the samples, the protein concentra-
tion was estimated by comparison of staining intensities of the enzyme
with known amounts of bovine serum albumin on Coomassie-stained
gels.
To determine flavin content of mutant forms of the poly-histidine
tagged alkyl-DHAP synthase, proteins were also purified batchwise.
For this purpose, 22 ml of isopropyl-b-D-thiogalactopyranoside-induced
E. coli culture expressing the mutant protein was harvested by centrif-
ugation and lysed in 1 ml of the lysis buffer described above. After
clearing of the lysate by centrifugation, the supernatant was added to
150 ml of ProbondTM metal-binding resin charged with NiCl2. The
recombinant protein was allowed to bind to the material for 0.5 h. The
material was washed three to four times with the washing buffer
described above, and proteins were eluted with 750 ml of elution buffer.
Fluorescence Detection of Flavin—Fluorescence spectra were re-
corded with a Photon Technology International Quantum Master fluo-
rimeter with a slit width of 2 nm. Fractions containing purified alkyl-
DHAP synthase were denatured with 7 M urea, and excitation and
emission scans were recorded as indicated using 1-ml cuvettes. Spectra
were routinely corrected for background fluorescence of the buffer. The
amount of flavin was quantified by comparing the emission of the
sample with the emission of known amounts of reference FAD in the
same buffer. For determination of flavin content in mutant forms of the
poly-histidine tagged guinea pig protein, 600-ml aliquots of the eluates
containing the purified proteins were adjusted to 7 M urea (end volume,
1 ml), and flavin fluorescence was quantified by integration of the
emission between 520 and 560 nm (excitation wavelength, 470 nm). The
flavin fluorescence was normalized for differences in the concentration
of the purified mutant proteins. For this purpose, relative amounts of
purified alkyl-DHAP synthase in the eluates were determined by quan-
tification of staining intensities on Coomassie Brilliant Blue stained
SDS-PAGE gels with a Bio-Rad GS-700 imaging densitometer.
In Vitro Transcription/Translation—The construct encoding poly-
histidine tagged mature guinea pig alkyl-DHAP synthase cloned down-
stream of the T7 promotor was used (15). The coupled T7 in vitro
transcription/translation reactions were done according to the manu-
facturer’s instructions (Promega) without radioactive label. The total
volume of each reaction was 50 ml, and approximately 1 mg of plasmid
DNA was used per reaction. Reactions were performed in the presence
or absence of FAD (10 mM) or FMN (10 mM). Formation of the protein
was monitored by analyzing an aliquot of 5 ml of the reaction by
Western blot immunodetection (19). Aliquots of 10 and 20 ml were used
for the determination of alkyl-DHAP synthase activity. Substrate prep-
aration and activity assays were performed as described previously (20)
with a slight modification in buffer composition. The following assay
conditions were used: 50 mM potassium phosphate (pH 7.5), 50 mM NaF,
5 mM dithiothreitol, 5 mM EDTA, 0.1% Triton X-100, 240 mM palmitoyl-
DHAP, and 110 mM [1-14C]hexadecanol (9000 dpm/nmol) in a total
volume of 75 ml.
Site-directed Mutagenesis of Histidine 300, Histidine 615, and His-
tidine 616—The histidine residues at position 300, 615, and 616 in the
poly-histidine tagged form of the enzyme were replaced separately by
alanines using the Quickchange site-directed mutagenesis method ac-
cording to the manufacturer’s instruction (Stratagene). Incorporation of
the mutagenic oligonucleotides into the construct was checked by re-
striction analysis and nucleotide sequencing. The mutant proteins (de-
noted as H300A, H615A, and H616A, respectively) were expressed in E.
coli strain BL21(DE3), and expression levels were found to be compa-
rable with those of the wild type enzyme. Enzyme activies were meas-
ured in total cell lysates as described (14). Flavin content was deter-
mined by measuring fluorescence as described above.
Construction and Purification of a Maltose-binding Protein-Guinea
Pig Alkyl-DHAP Synthase Fusion—The cDNA encoding guinea pig al-
kyl-DHAP synthase was excised from the pET-15b vector with XhoI and
ligated into the SalI site of a pMAL-c2 vector. This construct allows the
expression of mature guinea pig alkyl-DHAP synthase (amino acids
75–658) as a C-terminal fusion to the maltose-binding protein under
control of the tac promotor. This enables the purification of the enzyme
in a single step by affinity chromatography (27). The construct was
transformed into E. coli strain DH5a. An overnight culture (70 ml) was
diluted in 700 ml of fresh LB medium containing 50 mg/ml ampicillin,
and cells were grown at 37 °C. Cells were induced with 0.5 mM isopro-
pyl-b-D-thiogalactopyranoside at an A600 of 0.7 and grown for an ad-
ditional 3 h. Cells were harvested by centrifugation and resuspended in
20 ml of buffer A (20 mM Tris/HCl, pH 7.5, 200 mM NaCl, 2 mM EDTA,
0.2% Triton X-100, 2 mM dithiothreitol) supplemented with 0.2 mg/ml
lysozyme on ice for 0.5 h. The suspension was sonicated five times for
30 s, and the lysate was cleared by centrifugation (12,000 3 g, 15 min
at 4 °C). The supernatant was applied onto an amylose resin column
(volume, 4 ml) with a flow rate of 18 ml/h. The column was washed with
four column volumes of buffer A, and thereafter the recombinant MBP-
alkyl-DHAP synthase was eluted with 20 mM Tris/HCl (pH 7.5), 2 mM
EDTA, 2 mM dithiothreitol, 0.2% Triton X-100, and 10 mM maltose.
Absorption spectra were recorded on a Hitachi 150-20 spectrophotom-
eter. The concentration of FAD was calculated from the absorption at
450 nm in the presence of 0.5% SDS using 11.3 mM21 cm21 as molar
extinction coefficient (28). The substrates palmitoyl-DHAP and hexa-
decanol were added to the purified enzyme as sonicates in 0.2% Triton
X-100.
Stopped Flow Kinetics—Stopped flow kinetics were carried out with
a Hi-Tech SF-51 stopped flow apparatus equipped with a Hi-Tech M300
monochromator diode-array detector (Salisbury, UK). All kinetic exper-
iments were performed at 25 °C in 20 mM Tris/HCl (pH 7.5), 2 mM
dithiothreitol, 2 mM EDTA, and 0.2% Triton X-100. Spectral scans were
collected each 10 ms from 300 to 600 nm. In each experiment 96 scans
were collected. Deconvolution analysis of spectral data was performed
using the Specfit Global Analysis program version 2.10 (Spectrum
Software Assn., Chapel Hill, NC). To determine the rate of enzyme
reduction, alkyl-DHAP synthase was mixed with a solution containing
200 mM palmitoyl-DHAP resulting in a final concentration of 100 mM
SCHEME 1. Reaction catalyzed by alkyl-DHAP synthase. R1 and
R2 represent aliphatic chains.
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after mixing. For generation of the reduced enzyme intermediate com-
plex, the enzyme was titrated with an excess of palmitoyl-DHAP (100
mM). By mixing the reduced enzyme species with a solution of 200 mM
hexadecanol, reoxidation of the reduced enzyme could be monitored.
Analytical Procedures—SDS-PAGE was done according to Laemmli
(29). Protein was determined according to Bradford (30) using bovine
serum albumin as standard.
RESULTS
Recombinant poly-histidine tagged alkyl-DHAP synthase
was purified in a single purification step to apparent homoge-
neity from E. coli (Fig. 1). To monitor for the presence of flavin
fluorescence, an emission scan was recorded (excitation wave-
length, 470 nm) from both the native enzyme as well as enzyme
denatured in 7 M urea. As can be seen in Fig. 2A, a clear
fluorescence is observed in case of the denatured enzyme with
a maximum of about 525 nm, which is characteristic for flavin.
The fluorescence yield is relatively low in the native state,
showing that the protein effectively quenches the flavin fluo-
rescence. An excitation scan was obtained with the denatured
enzyme (emission wavelength, 530 nm; Fig. 2B), which is very
characteristic for flavin and resembles the absorption spec-
trum. The molar ratio between flavin and protein was esti-
mated to be around 0.15–0.25, which shows that only a small
part of the enzyme has taken up a flavin cofactor. Nevertheless,
because the protein sample appears to be rather pure on SDS-
PAGE (Fig. 1, lane 3) it is unlikely that this flavin fluorescence
is due to another contaminating flavoprotein.
In previous in vitro transcription/translation experiments
(17), we were unable to generate active enzyme despite ade-
quate expression of the protein. If indeed alkyl-DHAP synthase
is a FAD-dependent enzyme, this may have been caused by the
absence of this particular cofactor. To investigate this, the
histidine tagged guinea pig alkyl-DHAP synthase was ex-
pressed in a coupled in vitro transcription/translation system
in the absence or presence of either FAD or FMN (Fig. 3). As
can be seen in the Western blot analysis (Fig. 3B), the enzyme
is expressed to comparable levels in the incubations with no
cofactor, with FAD, or with FMN when the DNA template is
present. However, only in the FAD-containing incubation does
alkyl-DHAP synthase activity become clearly detectable. This
provides clear evidence that alkyl-DHAP synthase is depend-
ent on FAD, although it does not catalyze a net redox reaction.
It is also shown that FMN cannot replace FAD. This result is in
line with the observation that alkyl-DHAP synthase shows
homology toward FAD containing enzymes, which contain a
conserved domain that specifically interacts with the ADP part
of the FAD molecule (24).
In a previous study we prepared single amino acid mutants
of the poly-histidine tagged enzyme as well as C-terminal de-
letion mutants (14). Because histidine may play an important
role in the catalytic mechanism (14), we changed in addition all
remaining conserved histidines (His300, His615, and His616) into
alanines in this study. The inactivity of a given mutant may
result from replacement of essential catalytic amino acid resi-
dues or from misfolding of the protein, which may be reflected
by defective FAD binding. Therefore, we examined for all avail-
able mutant enzymes whether flavin content was comparable
with the wild type content by assaying batch purified protein
for flavin fluorescence. In Table I, the activity and flavin con-
FIG. 1. One-step purification of poly-histidine tagged guinea
pig alkyl-DHAP synthase with affinity chromatography. Lane 1,
molecular mass markers (in kDa); lane 2, starting material (bacterial
supernatant) (3 ml); lane 3, pool of fractions containing the purified
enzyme (12.5 ml).
FIG. 2. Fluorescence of purified re-
combinant guinea pig alkyl-DHAP
synthase. A, emission of the enzyme in
the urea-denatured state (spectrum I) and
the native state (spectrum II). Excitation
wavelength was 470 nm. B, excitation
scan of the urea denatured enzyme at
emission wavelength of 530 nm.
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tent of the mutant proteins are given. Certain mutant enzymes
have nondetectable activities accompanied by reduced FAD
binding (H300A and the deletion mutant pADSD5 missing the
last five C-terminal residues). Other mutant proteins have
nondetectable or strongly reduced activity, whereas flavin con-
tent is near normal (R419H, R419K, H616A, and H617A).
Because the poly-histidine tagged protein readily loses activ-
ity upon purification, we changed to another affinity tag, i.e.
the maltose-binding protein. Alkyl-DHAP synthase activities
per mg of E. coli protein in lysates of cells expressing the
MBP-alkyl-DHAP synthase fusion were comparable with the
values found for the poly-histidine tagged form (1–3 milliunits/
mg) (15). Approximately 60% of the enzyme activity did not
bind to the amylose resin affinity column. The enzyme eluted
as a yellow protein from the affinity column when a buffer
containing 10 mM maltose was applied. About 40% of the ap-
plied alkyl-DHAP synthase activity was recovered in the puri-
fied fractions. SDS-PAGE analysis showed that the recombi-
nant fusion protein (109 kDa) in the eluate was nearly
homogeneous. The purified MBP-alkyl-DHAP synthase con-
tained 0.28–0.30 mol FAD/mol protein. The turnover number
of the freshly purified recombinant enzyme in the standard
activity assay (20) was determined at 1.0 s21, using the FAD
concentration (derived by either the A450 value or by fluores-
cence measurements) to determine the amount of active ho-
loenzyme. This value corresponds to 900 nmol/min/mg for a
65-kDa protein, which is somewhat higher than the value of
357–640 nmol/min/mg previously determined for the enzyme
purified from guinea pig liver (20).This small difference can
easily be explained by the lability of the enzyme during the
elaborate multi-step purification procedure and inactivation by
freeze-thawing during storage.
Fig. 4 shows a UV-visible absorption spectrum of the purified
protein, in the native state (spectrum A) as well as in the
presence of 0.5% SDS (spectrum B). The observed spectrum for
the native protein is for a flavoprotein displaying two typical
flavin absorption maxima at around 375 and 458 nm with
shoulders at around 440 and 490 nm. Upon unfolding by SDS,
a typical FAD spectrum appears with two unresolved absorp-
tion maxima.
To investigate whether the redox state of the flavin cofactor
changes because of interaction of the enzyme with the sub-
strate, visible absorption spectra of alkyl-DHAP synthase were
recorded in the absence of substrate, in the presence of palmi-
toyl-DHAP, and in the presence of both palmitoyl-DHAP and
hexadecanol. Upon addition of palmitoyl-DHAP, a dramatic
change in the visible absorption spectrum is observed (Fig. 5,
spectrum B). The disappearance of the absorption peaks at 375
and 458 nm is consistent with the FAD cofactor being reduced.
Apparently, the substrate acyl-DHAP is oxidized by the en-
zyme. Inasmuch as these spectra were collected under aerobic
atmospheric conditions, we conclude that the reduced flavin in
the native enzyme is effectively protected against reoxidation
by molecular oxygen from the air. In contrast, when the incu-
bation mixture of enzyme plus palmitoyl-DHAP was treated
with 0.5% SDS (conditions as in Fig. 4, spectrum B) prior to
recording the absorption spectrum, a spectrum of oxidized FAD
identical to that shown in Fig. 4 (spectrum B) was observed
FIG. 3. In vitro transcription/translation of guinea pig alkyl-
DHAP synthase in the absence or presence of FAD or FMN.
Reactions were performed without or with DNA template as indicated.
The absence of cofactor and the presence of either FAD (10 mM) or FMN
(10 mM) in the reaction mixtures is also indicated. A, enzyme activities
in the reaction mixtures. B, Western blot immunostaining of alkyl-
DHAP synthase.
TABLE I
FAD content and enzyme activities of mutant alkyl-DHAP synthases
Both FAD content (determined by fluorescence) and enzyme activities
are expressed as percentages of wild-type values. Values are the means
of at least three independent experiments. ND, not detectable (,0.1% of
wild type activity). FAD content and enzyme activities of the R419H
mutant enzyme are related to the corresponding hybrid wild type con-
struct (pControl as described in Ref. 4). pADSD5, the C-terminal 5-a-













a *, values derived from previous studies (4,14).
b This mutant corresponds to the pMutant construct in Ref. 4 and
represents a guinea pig-human hybrid enzyme.
FIG. 4. Absorption spectra of isolated MBP-alkyl-DHAP syn-
thase in the native state (A) or denatured with 0.5% SDS (B).
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(data not shown). This indicates that the reduced FADH2 in the
native enzyme becomes readily oxidized by molecular oxygen
upon denaturation of the enzyme.
The addition of hexadecanol resulted in a somewhat turbid
sample because of the low solubility of this substrate. In rou-
tine activity measurements this is prevented by incubating the
enzyme with a mixed sonicate of acyl-DHAP and hexadecanol,
which gives clear solutions of mixed micelles. However, cloud-
iness of the samples is an inherent property of the system when
the hexadecanol has to be added separately and after the acyl-
DHAP, as had to be done in the experiments described in Fig.
5. Even though the spectrum is complicated by light scattering,
the reappearance of the characteristic oxidized flavin absorp-
tion peaks at around 375 and 458 nm, including the shoulders
at around 440 and 490 nm, became clearly visible. Thus, the
addition of this second substrate to the acyl-DHAP reduced
enzyme appears to reoxidize, at least in part, the flavin (Fig. 5,
spectrum C).
The reduction of the enzyme upon addition of the palmitoyl-
DHAP was studied in more detail using the stopped flow tech-
nique (Fig. 6). Upon mixing alkyl-DHAP synthase with palmi-
toyl-DHAP, a rapid decrease in absorbance around 455 nm
indicates that the flavin is efficiently reduced (Fig. 6). Decon-
volution of the spectral scans showed that the oxidized enzyme
is reduced in a monophasic process at a rate of 0.98 6 0.04 s21.
From the finally formed spectrum (Fig. 6, inset) it can be
concluded that the enzyme is effectively reduced by palmitoyl-
DHAP, indicating that the reaction with the flavin is essen-
tially irreversible. When spectral changes were followed for a
longer period (50 s) no other spectral species could be identi-
fied, indicating that the reduced enzyme species is remarkably
stable. Stopped flow measurements were also used to monitor
the reoxidation of the palmitoyl-DHAP reduced enzyme (data
not shown). Although the measurements were hampered by the
poor solubility of hexadecanol resulting in perturbation of the
spectra (Fig. 5, spectrum C), a relative fast reoxidation of the
enzyme could be observed as evidenced by an increase in ab-
sorbance between 400 and 500 nm. The estimated rate constant
for reoxidation by 200 mM hexadecanol is 15 s21. These data
support the data presented in Fig. 5, i.e. acyl-DHAP reduced
enzyme is reoxidized by hexadecanol.
DISCUSSION
The observation that alkyl-DHAP synthase exhibits homol-
ogy to FAD containing oxidoreductases (16, 24), especially in
the FAD-binding part, led us to investigate a possible role of
FAD in this enzyme. Although alkyl-DHAP synthase does not
catalyze a net redox reaction, we could convincingly demon-
strate the presence of this cofactor associated with the enzyme
by fluorescence properties (Fig. 2) and absorption spectra (Fig.
4) of the purified enzyme and by showing that enzyme activity
is dependent on this cofactor (Fig. 3). Nevertheless, the recom-
binant guinea pig enzymes purified from E. coli (either as a
poly-histidine tagged form or as a MBP fusion protein) did
contain less than 1 mol FAD/mol of alkyl-DHAP synthase mon-
omer. This may be due to high expression levels or inefficient
FIG. 5. Changes in absorption spectra of MBP-alkyl-DHAP syn-
thase as a result of the consecutive addition of the substrates
palmitoyl-DHAP and hexadecanol, respectively. Spectrum A, en-
zyme without substrate added; spectrum B, enzyme after the addition of
palmitoyl-DHAP (final concentration, 0.1 mM); spectrum C, enzyme
after addition of hexadecanol (final concentration, 0.15 mM) to the
mixture presented in spectrum B. Like in all other figures the spectra
were recorded under aerobic atmospheric conditions.
FIG. 6. A, spectral changes observed upon mixing of alkyl-DHAP
synthase with palmitoyl-DHAP (final concentration, 100 mM). A selec-
tion of the original spectral scans is shown (from 6 to 3006 ms with
intervals of 200 ms). The inset shows spectra obtained after deconvolu-
tion of the original spectral scans where the upper line represents the
initial spectrum of oxidized enzyme and the lower line shows the palmi-
toyl-DHAP reduced alkyl-DHAP synthase species. The spectral data
were fit with a one-exponential function (A 3 B) resulting in a rate
constant of 0.98 s21. B, absorbance changes observed upon mixing
alkyl-DHAP synthase with palmitoyl-DHAP (final concentration, 100
mM) when monitored at 455 nm. The original data are shown (from 6 to
4756 ms with intervals of 50 ms). The data could satisfactorily be fitted
according to a monophasic process using the rate constant (0.98 s21)
obtained by deconvolution of the original spectra.
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folding. The latter explanation would be in line with the obser-
vation that most of the poly-histidine tagged enzyme precipi-
tates as inactive inclusion bodies (15).
It is most likely that the native enzyme, as initially purified
in our laboratory from guinea pig liver (20), consists of flavin
and protein in a 1:1 molar ratio. However, it is not feasible to
obtain the amounts of enzyme required for the studies de-
scribed in this paper by the elaborate multi-step purification
procedure from guinea pig liver. This procedure yielded an
enzyme with a turnover number of 0.4–0.7 s21. When the
turnover number for the MBP-alkyl-DHAP synthase fusion
enzyme employed in this paper was calculated from activity
measurements and using enzyme concentrations deduced from
its FAD content, i.e. based on the amount of enzyme with a 1:1
molar ratio of flavin and protein, a value of 1.0 s21 was ob-
tained. In view of the difficulties encountered in accurate de-
termination of the protein content of the small amount of the
enzyme purified from guinea pig liver (20) and the likelihood of
enzyme inactivation during the elaborate purification proce-
dure, we conclude that the turnover numbers are in fact very
close. This indeed suggests that the native enzyme very likely
contains equimolar amounts of FAD and protein. These consid-
erations then also imply that the recombinant enzyme serves
as a good model for the native enzyme, provided its quantity is
expressed based on its FAD content.
Inactivity of certain mutant enzymes may also be due to
misfolding of the mutant rather than a mere replacement of an
active site residue. We reasoned that when the FAD content of
such a mutant is clearly decreased compared with the wild type
enzyme, the mutation probably affects the structural integrity
of the protein. Therefore we investigated the FAD content of all
available mutant forms of the poly-histidine tagged guinea pig
enzyme (described in Ref. 14 and in this study). The amino acid
residues chosen to be mutated are all conserved between the
mammalian alkyl-DHAP synthases and the C. elegans and
Dictyostelium homologs. Two mutant forms (H300A and a de-
letion mutant pADSD5 lacking the last five C-terminal resi-
dues) clearly exhibit reduced FAD binding (Table I). In line
with this finding is that histidine 300 is located in the FAD-
binding domain of the enzyme (24) and may be an important
structural residue essential for FAD binding. Furthermore,
equally in line with these results is the observation that the
extreme C-terminal part of the enzyme also constitutes part of
the FAD-binding domain (24). The inactivity of these two mu-
tant proteins can best be explained by incorrect folding of the
enzyme protein reflected by or caused by a reduced capacity to
bind FAD. Certain mutant proteins are inactive but neverthe-
less exhibit FAD binding capacities comparable with the wild
type enzyme (R419H, H616A, and H617A). These mutations
probably do not affect the overall tertiary structure of the
proteins, and therefore the corresponding mutated residues are
more likely to represent bona fide active site residues. In this
respect it is noteworthy that His615, His616, and His617 are part
of a highly conserved stretch of amino acids (amino acids 610–
620) that aligns with amino acids 499–509 of vanillyl alcohol
oxidase (Swiss-Prot accession number P56216). The latter
stretch forms a loop structure containing some active site res-
idues (23), i.e. Tyr503 and Arg504. In alkyl-DHAP synthase,
Arg419 is not located in the conserved FAD-binding part but
rather in the variable cap-domain. Because there is little se-
quence homology in this part among the members of this FAD-
binding protein family, no conclusions can be drawn about the
localization of this residue in the enzyme. Ser367 is a conserved
residue located in the adenine-binding part of the FAD-binding
domain, and the S367A mutant exhibits indeed reduced FAD
binding. However, this mutant has still some residual activity
(4% of wild type). Probably, the overall tertiary structure is
considerably disturbed by this mutation.
Clear differences are observed between the absorption spec-
tra of purified MBP-alkyl-DHAP synthase recorded in either
the presence or absence of SDS. In the absence of SDS signif-
icant aspecific light scattering is observed, which perturbs the
absorption spectra. Because the buffer does not exhibit any
absorbance above 300 nm, this must be due to the presence of
aggregates. Possibly, as the FAD cofactor is fully reactive with
substrate (Fig. 6), the apoform of alkyl-DHAP synthase present
in the sample is less stable and tends to aggregate. Further-
more, two clear shoulders are observed aligning the absorbance
maximum at 458 nm of the native enzyme, which disappear
after SDS denaturation. Such shoulders are frequently ob-
served in native flavoproteins (31, 32) and generally indicate
that the isoalloxazine part of the FAD molecule is in an envi-
ronment shielded from solvent.
Based on spectral properties, we could show that the flavin
part of the cofactor is actively involved in the reaction mecha-
nism (Fig. 5). Upon addition of the substrate palmitoyl-DHAP,
the formed absorption spectrum of the enzyme indicates that
the FAD cofactor is efficiently reduced. Apparently, palmitoyl-
DHAP directly reacts with the flavin cofactor donating two
electrons to the isoalloxazine ring. However, when long chain
fatty alcohol (hexadecanol) is added to the mixture, the FAD
cofactor is reoxidized.
Stopped flow measurements indicated a monophasic reduc-
tion of the FAD cofactor by palmitoyl-DHAP without any de-
tectable intermediates (Fig. 6). The spectrum formed upon
reaction with palmitoyl-DHAP represents a nearly fully re-
duced enzyme species, indicating that reduction is irreversible.
Further, no evidence could be obtained supporting formation of
a flavin N5 adduct during reduction because the reduced spec-
trum did not show any atypical features and was not fluores-
cent when excited at 360 nm (data not shown) (33). Therefore,
we assume that two electrons are directly transferred from the
substrate to the cofactor yielding FADH2. The rate of reduction
is in the same order as the turnover rate for the enzyme,
whereas reoxidation by hexadecanol of the reduced species
appears to be a relatively fast process. Combined with the
observation that oxidized enzyme is detected during turnover
(Fig. 5, spectrum C), these results suggest that the reductive
half-reaction is a major factor in determining the turnover rate.
These results clearly demonstrate the essential role of the FAD
cofactor in alkyl-DHAP synthase catalysis. As in other oxi-
doreductases, the FAD cofactor in alkyl-DHAP synthase cycles
between the oxidized state and reduced state. By unraveling
this unexpected and remarkable functional role of the flavin
cofactor in alkyl-DHAP synthase, we have broadened the range
of reactions known to be catalyzed by flavoproteins.
Earlier studies on the mechanism of the alkyl-DHAP syn-
thase reaction have shown that the pro-R hydrogen of the C-1
in the DHAP moiety is lost during the reaction (8–10) and that
the enzyme can also exchange the fatty acyl group in acyl-
DHAP for one from the medium (12). In both reactions the ester
linkage in acyl-DHAP is cleaved by an alkyl oxygen fission, i.e.
between the C-1 atom of the DHAP moiety and the oxygen of
the acyl chain, in which both oxygens from the ester linkage are
retained in the released fatty acid (6, 7). In crude microsomal
systems the amount of the pro-R hydrogen lost exceeded the
formation of alkyl-DHAP (8, 11), presumably because of the
presence of free fatty acids either from the enzyme preparation
or produced by hydrolysis of acyl-DHAP. However, with a de-
lipidated and 1000-fold purified enzyme preparation devoid of
acyl-DHAP acylhydrolase activity, the pro-R hydrogen loss be-
came equivalent to the amount of the fatty acid exchange (8).
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Thus, the interpretation of studies on the mechanism of alkyl-
DHAP synthase has been seriously hampered in the past by the
use of crude enzyme preparations exhibiting disturbing side
reactions. However, the acyl exchange reaction appears to be a
genuine property of alkyl-DHAP synthase that we have con-
firmed with the recombinant enzyme (14).
Based on the findings presented in this paper that alkyl-
DHAP synthase contains FAD, which becomes reduced upon
addition of acyl-DHAP, it is tempting to assume that the pro-R
hydrogen is lost in a step in which the C-1 atom of the DHAP
moiety becomes oxidized to yield an intermediate X of which
the precise structure still has to be resolved. To investigate
whether such an intermediate would be covalently linked to the
enzyme, as was proposed in the reaction mechanism put for-
ward previously by Brown and Snyder (8), the enzyme was
incubated with palmitoyl-[14C]DHAP and then analyzed by
SDS-PAGE. No 14C label was detected in the enzyme protein
band supporting a noncovalent binding of the intermediate.
When the incubation mixture of enzyme and palmitoyl-[14C]D-
HAP was distributed over chloroform/water layers, a clear in-
crease in water-soluble radioactivity was seen in comparison
with similar extractions without enzyme. This indicates that
the enzymatic reaction produces not only reduced cofactor but
also a water-soluble intermediate that can be extracted from
the enzyme. At present we cannot completely exclude the pos-
sibility that this water-soluble compound represents DHAP
formed by hydrolysis of palmitoyl-DHAP rather than an inter-
mediate formed in dependence of FAD. Yet the release of pal-
mitic acid followed by reduction of the enzyme flavin by the
DHAP is considered a less likely reaction sequence. First, this
sequence would require an additional enzymatic activity,
namely a separate acyl-ester hydrolysis reaction. Brown and
Snyder (8) concluded from earlier studies on the reaction mech-
anism of this enzyme that although whole microsomes contain
at least two acylhydrolases for acyl-DHAP, purified prepara-
tions of alkyl-DHAP synthase do not form DHAP from acyl-
DHAP. Assuming this is true it means that no hydrolase ac-
tivity per se is present in the enzyme. Second, acylhydrolase
reactions are known to proceed by acyl oxygen fission involving
cleavage of the acyl to oxygen bond (6, 34). A separate hydro-
lase step is therefore difficult to reconcile with the observations
that both oxygens from the acyl ester bond are retained by the
fatty acid (6, 7). Third, and more conclusive, we found that
enzyme flavin is not reduced upon addition of dihydroxyaceto-
nephosphate. This result was already expected from earlier
observations. If the oxidized intermediate X would be formed
from DHAP, either produced from acyl-DHAP in a separate
deacylation step or from added DHAP, then this added DHAP
would be expected to be a substrate for alkyl-DHAP synthesis.
Early experiments by Hajra (35) have shown that acyl-DHAP,
but not DHAP, is the substrate for alkyl-DHAP synthesis.
Thus, the FAD-dependent formation of the oxidized DHAP
moiety intermediate X directly from palmitoyl-DHAP is consid-
ered more plausible than its formation from DHAP.
In accord with and extending previous proposals (6, 8, 36),
the oxidized DHAP moiety intermediate X in its binary com-
plex with FADH2-enzyme is then postulated to react with ei-
ther a fatty alcohol or a fatty acid. At least the reaction with a
fatty alcohol to generate the product alkyl-DHAP appears to be
accompanied by regeneration of the FAD cofactor (Fig. 5). This
postulate suggests that the enzyme may act via an ordered
sequential mechanism, unless one considers the binary com-
plex of reduced enzyme and oxidized DHAP moiety intermedi-
ate X as the modified enzyme intermediate obligatory in a
ping-pong reaction in which the first product (fatty acid) is
formed before the second cosubstrate (alcohol) comes in. This
would be in line with the most recent kinetic analyses, which
favored a ping-pong mechanism (13, 14). However, this inter-
pretation was entirely based on the appearance of a set of
parallel lines in double-reciprocal plots of reaction velocity
versus palmitoyl-DHAP concentrations measured at different
hexadecanol concentrations. In theory, an ordered sequential
mechanism requires that the family of lines in such double-
reciprocal plots intersect to the left of the ordinate. However, as
pointed out by Dalziel (37) and Porter et al. (38), such intersec-
tions may be so far to the left that the lines will appear to be
parallel, and the ordered sequential mechanism will behave
like a ping-pong mechanism. A full analysis of all intermedi-
ates and true kinetic constants is required to decide between
these reaction mechanisms.
In summary, this paper has shown the presence of the cofac-
tor FAD in alkyl-DHAP synthase and documents its require-
ment for enzyme activity and its reduction and reoxidation
upon stepwise addition of substrates. Stopped flow studies
established that the reduction is considerably slower than the
reoxidation. In addition, these experiments served to demon-
strate that the reduction of flavin takes place in a single step,
with no evidence for the formation of radical intermediates or
charge-transfer complexes and that the reduced flavin is
formed at rates sufficient to account for the catalytic activity of
the enzyme. We believe these new findings set the stage for
future detailed kinetic and mechanistic studies along com-
pletely new lines in comparison with the previous studies on
the mechanism of the unique enzymatic reaction of glycero-
ether bond formation.
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